proceedings of 40th annual general meeting of ads diagnostic limited
Awaiting price reaction for this filing.
ADS Diagnostic Limited held its 40th AGM on 29 September 2025 via video conferencing. Shareholders approved the audited financial statements for FY 2024-25 and declared a dividend on equity shares for the year. Dr. Vivek Sehgal was re-appointed as Director by rotation. Dr. Gautam Sehgal was re-appointed as Managing Director for a fresh 5-year term (1 June 2025 to 31 May 2030), with a monthly salary of Rs. 5,11,615, HRA of Rs. 2,35,076, club membership up to Rs. 12,000 per year, plus a 20% annual increment and PF/Gratuity benefits. The statutory auditors' report was non-qualified, and all resolutions were passed with the requisite majority.
Existing shareholders will receive the FY25 dividend, providing a direct cash return. The MD's reappointment with an automatic 20% annual salary hike locks in rising fixed costs over the next five years, which investors should weigh against the company's growth and profitability.